Conduct of clinical trials in developing countries: a perspective

Area of Science:

• Global Health
• Clinical Research
• Developing Economies

Background:

• Research output in developing nations remains insufficient, with clinical trials representing a small portion.
• Many clinical trials conducted in developing countries are designed and led by researchers from developed nations.
• Vulnerable populations in developing countries face unique challenges in clinical trial participation.

Purpose of the Study:

• To offer a comprehensive overview of contextual factors influencing clinical trial conduct in developing countries.
• To identify key challenges and propose strategies for improving clinical trial research in these regions.

Main Methods:

• Literature review of existing research on clinical trials in developing countries.
• Analysis of factors affecting trial design, execution, and outcomes.
• Synthesis of challenges related to infrastructure, personnel, and population vulnerability.

Main Results:

• Clinical trials in developing countries are often inadequately represented and externally driven.
• Significant barriers include illiteracy, poverty, weak research infrastructure, and healthcare system fragmentation.
• Lack of experienced investigators and trained support staff further impedes research.

Conclusions:

• There is a critical need for context-specific and socially relevant clinical trial designs.
• Overcoming challenges necessitates meticulous planning and collaborative partnerships between sponsors, host-country researchers, government bodies, and communities.
• Such collaborations can foster adherence to international guidelines and ensure research addresses the specific health needs of developing countries.